Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.73%634.43M | -47.18%718.71M | -240.29%-556.81M | 11.47%338.7M | 53.59%490.45M | 31.07%446.37M | 17.73%1.36B | -1.72%396.9M | 1.21%303.84M | 27.56%319.33M |
| Cost of revenue | -19.50%561.2M | -38.35%697.12M | -236.76%-483.77M | 30.45%334.28M | 66.64%439.8M | 58.38%406.81M | 24.68%1.13B | 13.30%353.73M | 6.91%256.25M | 35.74%263.92M |
| Gross profit | 239.21%73.23M | -90.61%21.59M | -269.19%-73.04M | -90.70%4.42M | -8.59%50.65M | -52.74%39.56M | -7.59%229.86M | -52.89%43.17M | -21.35%47.58M | -0.87%55.41M |
| Operating expense | 9.61%365.3M | -3.98%333.28M | -17.88%62.77M | 10.78%94.74M | 14.65%76.32M | -16.12%99.45M | -31.77%347.08M | -37.65%76.43M | -46.34%85.52M | -35.29%66.57M |
| Staff costs | ---- | 46.59%188.79M | ---- | ---- | ---- | ---- | -12.02%128.79M | ---- | ---- | ---- |
| Selling and administrative expenses | 9.61%365.3M | 510.98%333.28M | 129.04%62.77M | 10.78%94.74M | 14.65%76.32M | -16.12%99.45M | 327.17%54.55M | 42.12%-216.1M | -46.34%85.52M | --66.57M |
| -Selling and marketing expense | 1.78%272.18M | --267.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | 41.37%93.12M | 20.75%65.87M | 5.30%-204.65M | 10.78%94.74M | 14.65%76.32M | -16.12%99.45M | 327.17%54.55M | 42.12%-216.1M | -46.34%85.52M | --66.57M |
| Depreciation and amortization | ---- | -7.88%1.41M | ---- | ---- | ---- | ---- | -87.07%1.54M | ---- | ---- | ---- |
| -Depreciation | ---- | -7.88%1.41M | ---- | ---- | ---- | ---- | -87.07%1.54M | ---- | ---- | ---- |
| Rent and land expenses | ---- | -3.75%41.01M | ---- | ---- | ---- | ---- | --42.61M | ---- | ---- | ---- |
| Other operating expenses | ---- | -3.45%115.47M | ---- | ---- | ---- | ---- | -64.58%119.6M | ---- | ---- | ---- |
| Operating profit | 6.30%-292.07M | -165.91%-311.7M | -308.31%-135.8M | -138.09%-90.32M | -130.00%-25.68M | -71.82%-59.9M | 54.91%-117.22M | -7.48%-33.26M | 61.63%-37.94M | 76.24%-11.16M |
| Net non-operating interest income (expenses) | 100.03%2K | -24,666.67%-6.69M | 65K | -2.56M | -4.13M | -137.04%-64K | -3.85%-27K | 0 | 0 | 0 |
| Non-operating interest income | --2K | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Non-operating interest expense | --0 | 24,666.67%6.69M | ---65K | --2.56M | --4.13M | 137.04%64K | 0.00%27K | --0 | --0 | --0 |
| Net investment income | -98.93%97K | -36.70%9.03M | 0 | 0 | -96.18%200K | 36,670.83%8.83M | 94.61%14.26M | 73.70%1M | 143.90%8M | 137.68%5.23M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 22,088.81%700.28M | -89.70%291K | 48,531.63%237.32M | 217,125.56%195.32M | 29,279.12%267.35M | -74.76%3.16M | -63.16%2.83M | -115.84%-490K | -119.57%-90K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 4,742.43%199.36M | 282.17%4.12M | 11,930.00%1.2M | 2.72M | 102.35%80K | -90.09%112K | 97.55%-2.26M | 100.01%10K | 0 | -3.4M |
| Less:Restructuring and mergern&acquisition | --1.1M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -4,927.18%-201.09M | -276.21%-4M | ---1.3M | ---- | ---- | ---- | --2.27M | --0 | --0 | --3.4M |
| Less:Write off | 629.91%620K | -1,070.00%-117K | 1,070.00%97K | ---22K | ---80K | ---112K | -100.01%-10K | ---10K | --0 | --0 |
| Other non-operating income (expenses) | 576.09%933K | -97.48%138K | 73.96%-396K | -101.14%-26K | -82.69%349K | -92.20%211K | -40.05%5.49M | -132.74%-1.52M | 44.78%2.29M | 8.39%2.02M |
| Income before tax | -123.20%-91.68M | 509.06%395.18M | -335.12%-134.64M | 622.88%147.13M | 2,342.52%166.15M | 819.04%216.54M | 70.12%-96.61M | 71.96%-30.94M | 69.05%-28.14M | 82.56%-7.41M |
| Income tax | -11.00%5.06M | -36.24%5.68M | -27.70%2.76M | -100.53%-11K | -82.43%276K | 81.25%2.66M | 47.45%8.91M | 132.58%3.81M | 40.26%2.06M | 7.02%1.57M |
| Net income | -124.84%-96.73M | 469.14%389.5M | -295.32%-137.4M | 587.27%147.15M | 1,947.33%165.87M | 777.20%213.88M | 67.97%-105.52M | 68.97%-34.76M | 67.31%-30.2M | 79.57%-8.98M |
| Net income continuous operations | -124.84%-96.73M | 469.14%389.5M | -295.32%-137.4M | 587.26%147.14M | 1,947.13%165.87M | 777.22%213.88M | 67.97%-105.52M | 68.97%-34.76M | 67.31%-30.2M | 79.57%-8.98M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | |||||
| Net income attributable to the company | -124.84%-96.73M | 469.14%389.5M | -295.32%-137.4M | 587.27%147.15M | 1,947.33%165.87M | 777.20%213.88M | 67.97%-105.52M | 68.97%-34.76M | 67.31%-30.2M | 79.57%-8.98M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -124.84%-96.73M | 469.14%389.5M | -295.32%-137.4M | 587.27%147.15M | 1,947.33%165.87M | 777.20%213.88M | 67.97%-105.52M | 68.97%-34.76M | 67.31%-30.2M | 79.57%-8.98M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -124.73%-0.68 | 466.67%2.75 | -288.00%-0.97 | 595.24%1.04 | 1,771.43%1.17 | 786.36%1.51 | 72.63%-0.75 | 70.24%-0.25 | 71.62%-0.21 | 82.05%-0.07 |
| Diluted earnings per share | -124.73%-0.68 | 466.67%2.75 | -288.16%-0.9704 | 587.27%1.0392 | 1,771.43%1.17 | 786.36%1.51 | 72.63%-0.75 | 70.24%-0.25 | 71.18%-0.2133 | 82.05%-0.07 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |